tirzepatide brain health A novel therapeutic prospect: a dual-acting for Alzheimer's disease Tirzepatide on ingestive behavior in
Description
In the largest pharmacogenomics GWAS of GLP-1 medications to date (15,237 participants, replicated in the All of Us cohort), researchers identified a missense variant in GLP1R the gene encoding the very receptor that semaglutide and tirzepatide bind that significantly predicts how much weight a person loses on treatment
Explore the retatrutide dosing schedule from Phase 2 and 3 clinical trials: escalation protocol, weekly doses, and trial data
JAMA network open, 5(12), e2244912
Find meal plans, shopping lists and tons of gut health recipes.
Starting at 241 lb, she lost 90 lb (over 30% of her body weight) over 65 weeks without side effects
